{"id":"NCT01740089","sponsor":"Biocad","briefTitle":"Algeron (Cepeginterferon Alfa-2b) Compared With PegIntron (Peginterferon Alfa-2b) for Treatment of Chronic Hepatitis C","officialTitle":"Multicenter Open-label Randomized Prospective Clinical Study of Efficacy and Safety of Algeron (Cepeginterferon Alfa-2b) in Comparison With PegIntron (Peginterferon Alfa-2b) in the Combined Treatment of Chronic Hepatitis C","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2011-11","primaryCompletion":"2012-07","completion":"2013-12","firstPosted":"2012-12-04","resultsPosted":"2015-08-18","lastUpdate":"2015-08-18"},"enrollment":150,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hepatitis","Hepatitis C"],"interventions":[{"type":"DRUG","name":"Algeron","otherNames":["cepeginterferon alfa-2b"]},{"type":"DRUG","name":"PegIntron","otherNames":["Peginterferon alfa-2b"]},{"type":"DRUG","name":"Ribavirin","otherNames":[]}],"arms":[{"label":"Algeron 1.5 μg/kg","type":"EXPERIMENTAL"},{"label":"Algeron 2.0 μg/kg","type":"EXPERIMENTAL"},{"label":"PegIntron","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of the study is to demonstrate the noninferiority of Algeron 1.5 and 2.0 μg/kg/week in combination with ribavirin compared to PegIntron in combination with ribavirin in the treatment of chronic hepatitis C, and to determine therapeutic dose of Algeron.","primaryOutcome":{"measure":"Number of Randomized Patients Achieving Early Virologic Response (EVR) - Negative PCR Result for HCV RNA (< 15 IU/ml) or ≥ 2log10 Decrease of Viral Load After 12 Weeks of Study Treatment.","timeFrame":"12 weeks","effectByArm":[{"arm":"Algeron 1.5 μg/kg","deltaMin":47,"sd":null},{"arm":"Algeron 2.0 μg/kg","deltaMin":47,"sd":null},{"arm":"PegIntron","deltaMin":44,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["Russia"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":101},"commonTop":["Flu-like syndrome","Grade 1 anemia","Asthenia (weakness, fatigue)","Headache","Grade 1 thrombocytopenia"]}}